Outsourcing is the new modus operandi of the pharmaceutical industry. A large number of labs and Contract Research Organizations have sprung up to handle various requirements of the industry. Like any other niche, these companies vary in size.

Some CROs are behemoths with revenues in the billions and operations in several countries. Smaller CROs don’t match these numbers but continue to offer excellent services. At first glance, this seems like a David vs. Goliath scenario but…